Xolair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity
Condition:   Healthy Volunteers Interventions:   Biological: CMAB007;   Biological: Xoliar Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2023 Category: Research Source Type: clinical trials

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity
Condition:   Healthy Volunteers Interventions:   Biological: CMAB007;   Biological: Xolair Sponsor:   Taizhou Mabtech Pharmaceutical Co.,Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Zerafil ® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma
Conditions:   Allergic Asthma;   Uncontrolled Moderate to Severe Interventions:   Biological: Omalizumab (CinnaGen);   Biological: Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland) Sponsor:   Cinnagen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials